Bloomberg Originals
@business·5.1M subscribers·49.5K videos
Shkreli: No Regrets for Raising Drug Price
Posted
December 23, 2016
Views
6,370
Likes
83
Comments
36
Engagement
1.87%
December 23, 2016
6,370
83
36
1.87%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
3:08Now PlayingDec.23 -- Former Turing Pharmaceuticals CEO Martin Shkreli discusses the controversy surrounding his raising of pricing for the drug Daraprim and talks about his upcoming securities fraud trial on charges related to hedge funds he ran prior to Turing. He speaks on "Bloomberg Daybreak: Americas."
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
